Comparison of modern marker proteins in serum and synovial fluid in patients with advanced osteoarthrosis and rheumatoid arthritis

被引:0
作者
S. Andereya
N. Streich
B. Schmidt-Rohlfing
T. Mumme
R. Müller-Rath
U. Schneider
机构
[1] Aachen University Hospital,Department of Orthopaedic Surgery
[2] University of Heidelberg,Departement of Orthopaedic Surgery
来源
Rheumatology International | 2006年 / 26卷
关键词
MMP-13; Osteoarthritis; Rheumatoid arthritis; Synovial fluid; Serum;
D O I
暂无
中图分类号
学科分类号
摘要
Numerous studies have focused on the significance of modern marker proteins in the synovial fluid of the knee joint and in the serum both, for osteoarthritis (OA) and rheumatoid arthritis (RA). The relationship between the serum concentrations and the concentrations in the synovial fluid is still unclear. Synovial fluid and serum samples were obtained from 13 patients with advanced OA and from 8 patients with severe RA and concentrations of MMP-1, MMP-3, MMP-13, TIMP-1, COMP and MIA/CD-RAP were determined. All values were normalized against the total protein concentrations. Serum concentrations of MMP-13 in the RA-group were statistically higher than the synovial values (P<0.05). MMP-13 was the only marker protein that revealed distinct higher levels in the serum than in the synovial fluid. The study design allows only conclusions about advanced stages of RA and OA. Longitudinal investigations may provide further information about the value of MMP-13 as a potential marker to monitor the course of RA and OA.
引用
收藏
页码:432 / 438
页数:6
相关论文
共 173 条
[1]  
Yoshihara Y(2000)Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis Ann Rheum Dis 59 455-461
[2]  
Nakamura H(1996)Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4 J Biol Chem 271 30375-30380
[3]  
Obata K(1997)Activation mechanisms of matrix metalloproteinases Biol Chem 378 151-160
[4]  
Yamada H(1994)Structure and expression in breast tumors of human TIMP-3, a new member of the metalloproteinase inhibitor family Cancer Res 54 2091-2094
[5]  
Hayakawa T(1996)Practical significance of cytokine determination in joint fluid in patients with arthroses or rheumatoid arthritis Z Orthop Ihre Grenzgeb 134 381-385
[6]  
Greene J(1990)Discoordinate expression of stromelysin, collagenase and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts. Synergetic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression J Biol Chem 265 17238-17245
[7]  
Wang M(1994)Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthrosis and rheumatoid arthritis Lab Invest 70 807-815
[8]  
Liu YE(1993)Cytokine regulation of metalloproteinase gene expression J Cell Biochem 53 288-295
[9]  
Raymond LA(1993)The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP) and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis Arthritis Rheum 36 372-379
[10]  
Rosen C(1995)Significance of the levels of carboxy terminal type II procollagen peptide, chondroitin sulfate isomers, tissue inhibitor of metalloproteinases, and metalloproteinases in osteoarthritis joint fluid J Rheumatol Suppl 43 78-81